KALA BIO (27F) Q2 2026 Earnings Report
DE:27F Q2 2026 EPS Results
- Actual EPS
- -EUR 19.09
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 76.56
DE:27F Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- TBA
- Conference Call
- Thursday, August 6, 2026
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:27F Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 06, 2026 | 2026 (Q2) | ―-19.09 | -76.56 | 75.07% (+57.47) | |
| May 19, 2026 | 2026 (Q1) | ―-0.12 | -63.13 | 99.81% (+63.00) | |
| Mar 26, 2026 | 2025 (Q4) | -0.290.02 | -1.56 | 101.44% (+1.58) | |
| Nov 17, 2025 | 2025 (Q3) | -0.90-0.90 | -1.73 | 47.67% (+0.82) | |
| Aug 08, 2025 | 2025 (Q2) | -76.26-76.56 | -141.47 | 45.89% (+64.92) | |
| May 14, 2025 | 2025 (Q1) | ―-1.56 | -188.03 | 99.17% (+186.48) | |
| Mar 31, 2025 | 2024 (Q4) | -90.88-63.13 | -188.03 | 66.43% (+124.91) | |
| Nov 12, 2024 | 2024 (Q3) | -108.79-86.41 | -152.67 | 43.40% (+66.26) | |
| Aug 06, 2024 | 2024 (Q2) | -197.21-141.47 | -195.2 | 27.52% (+53.72) | |
| May 14, 2024 | 2024 (Q1) | -129.38-188.03 | -312.94 | 39.91% (+124.91) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
